Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Dynatronics Co. stock logo
DYNT
Dynatronics
$0.01
$0.04
$0.19
$653K0.311,976 shsN/A
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
$5.95
-0.8%
$6.06
$2.90
$23.42
$41.17M1.4374,495 shs109,826 shs
7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00%0.00%+800.00%+41.43%-87.79%
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
-3.54%+7.14%+80.18%+2.61%-51.99%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Dynatronics Co. stock logo
DYNT
Dynatronics
$0.01
$0.04
$0.19
$653K0.311,976 shsN/A
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
$5.95
-0.8%
$6.06
$2.90
$23.42
$41.17M1.4374,495 shs109,826 shs
7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00%0.00%+800.00%+41.43%-87.79%
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
-3.54%+7.14%+80.18%+2.61%-51.99%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00
N/AN/AN/A
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
2.43
Hold$58.00874.79% Upside

Current Analyst Ratings Breakdown

Latest DYNT and PSTV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/21/2026
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
Reiterated RatingSell (E+)
4/9/2026
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
Lower Price TargetBuy$475.00 ➝ $65.00
3/31/2026
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
Reiterated RatingBuyHold
3/19/2026
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
Reiterated RatingBuy$75.00
(Data available from 5/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Dynatronics Co. stock logo
DYNT
Dynatronics
$33.60M0.00N/AN/A$0.57 per share0.00
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
$5.21M7.83N/AN/A$0.72 per share8.26
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Dynatronics Co. stock logo
DYNT
Dynatronics
-$2.70M-$1.35N/AN/AN/A-8.35%-41.81%-9.56%5/11/2026 (Estimated)
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
-$22.39M-$31.00N/AN/AN/A-429.43%N/A-92.28%5/29/2026 (Estimated)

Latest DYNT and PSTV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/29/2026Q1 2026
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
-$0.8460N/AN/AN/A$0.97 millionN/A
3/12/2026Q4 2025
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
-$0.03$6.25+$6.28N/A$1.23 million$1.37 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/A
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Dynatronics Co. stock logo
DYNT
Dynatronics
0.25
1.21
0.60
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
N/A
1.23
1.23

Institutional Ownership

CompanyInstitutional Ownership
Dynatronics Co. stock logo
DYNT
Dynatronics
4.18%
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
3.28%

Insider Ownership

CompanyInsider Ownership
Dynatronics Co. stock logo
DYNT
Dynatronics
2.90%
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
2.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Dynatronics Co. stock logo
DYNT
Dynatronics
20016.05 million8.11 millionNot Optionable
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
206.86 million6.69 millionNot Optionable

Recent News About These Companies

Plus Therapeutics Appoints Eric J. Daniels, M.D.

New MarketBeat Followers Over Time

Media Sentiment Over Time

Dynatronics stock logo

Dynatronics NASDAQ:DYNT

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.

Plus Therapeutics stock logo

Plus Therapeutics NASDAQ:PSTV

$5.95 -0.05 (-0.83%)
Closing price 04:00 PM Eastern
Extended Trading
$5.96 +0.01 (+0.12%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. Its lead radiotherapeutic drug candidate is rhenium (186Re) obisbemeda, a patented radiotherapy that targets central nervous system cancers and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. The company also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere that is designed to treat various solid organ cancers comprising primary and secondary liver cancers by intra-arterial injection. It has license agreements with NanoTx, Corp. and The University of Texas Health Science Center at San Antonio. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.